TheraRadar
← Back
Data updated: Jun 28, 2026

EURAND PHARMA LTD

Biotech
Pharmaceuticals

EURAND PHARMA LTD is a biotechnology company with 1 FDA-approved products.

2009
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Biologics

EURAND PHARMA LTD's Key Drugs

EURAND PHARMA LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

EURAND PHARMA LTD's Recent FDA Approvals

New NDA/BLA approvals for EURAND PHARMA LTD over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

EURAND PHARMA LTD's Therapeutic Areas

Disease areas where EURAND PHARMA LTD has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

EURAND PHARMA LTD Pipeline Snapshot

Active clinical trials for EURAND PHARMA LTD across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling